The LAM Community Needs Your Help! Patient engagement is central to our progress of seeking safe and effective treatments, and ultimately a cure for LAM. When clinical trials do not reach their enrollment numbers, the question that was trying to be answered is unfortunately left unanswered.
We are looking for 25 more volunteers to participate in the MILED Trial, a research study that began in 2017 designed to answer the question, what if we start sirolimus early?

You may be eligible if you:
– Are an adult woman with LAM
– Have an FEV1 greater than 70% predicted
– Are not currently taking sirolimus

If this sounds like you or a loved one, please visit our website:https://thelamfoundation.org/miled and contact Susan McMahan, the MILED Project Manager, at susan.mcmahan@uc.edu or 513-558-4376 to participate.